Integrin β3 (Y2/51) Antibody sc-20058 from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Integrin β3 (Y2/51) Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Integrin β3 (Y2/51) Antibody

The Integrin β3 (Y2/51) Antibody from Santa Cruz Biotechnology, Inc. is a Mouse Monoclonal antibody to Integrin beta 3, and ITGB3. This antibody recognizes Homo Sapiens, Human, Mouse, and Rat antigen. The Integrin β3 (Y2/51) Antibody has been shown to work in the following applications: Flow Cytometry, Immunofluorescence, and Immunohistochemistry - fixed.

Description

Integrin beta 3 (Y2/51)

Product Specs
ItemIntegrin β3 (Y2/51) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-20058
Antibody TypePrimary Antibodies
NCBI Gene AliasesGT, CD61, GP3A, BDPLT24, BDPLT2, GPIIIa, BDPLT16, INGRB3, GT2
Quantity200 µg/ml
CloneY2/51
Reactivitymouse, rat, human
ApplicationsIF, IHC(P), FCM
FormatPurified
Conjugate/TagUnconjugated
ClonalityMonoclonal
Hostmouse
NCBI Full Gene Nameintegrin subunit beta 3, integrin beta 3
TargetIntegrin beta3
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healingBiomaterialsOctober 1, 2011Caiado F, Carvalho T, Silva F, Castro C, Clode N, Dye JF, Dias S.

(2) Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cellsThe Journal of biological chemistryDecember 10, 2010Serpa J, Caiado F, Carvalho T, Torre C, Gonçalves LG, Casalou C, Lamosa P, Rodrigues M, Zhu Z, Lam EW, et al.

(3) Cyclic alphavbeta6-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinomaHead & neckFebruary 1, 2010Hsiao JR, Chang Y, Chen YL, Hsieh SH, Hsu KF, Wang CF, Tsai ST, Jin YT.

(4) In vitro comparison of human fibroblasts from intact and ruptured ACL for use in tissue engineeringEuropean cells & materialsDecember 17, 2007Brune T, Borel A, Gilbert TW, Franceschi JP, Badylak SF, Sommer P.

Be the First to Write a Review!